FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:188-192 July 10, 2003 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Drazen, J. M. Related Article by Miller, F. G. Related Article by Karlawish, J. H.T. Related Article by Steinbrook, R. PubMed Citation

To the Editor: Regarding the study by the Acute Respiratory Distress Syndrome (ARDS) Network, discussed by Steinbrook (April 3 issue),¹ some may wonder whether the institutional review boards (IRBs) had enough information to evaluate the risks of this study properly. As a member of an IRB that reviewed this protocol, I want to assure readers that there was indeed a very diligent review. The local consent form carefully and properly represented the risks involved in the study. There was ongoing review of adverse events, which were assiduously reported by the investigators. The public overall and the research subjects in particular . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.